Abhay U. Nayak - 15 Jun 2026 Form 3 Insider Report for Zoetis Inc. (ZTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
17 Jun 2026, 16:45:34 UTC
Prior SEC filing
11 Oct 2022
Next SEC filing
14 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brenda Santuccio, as Attorney-in-Fact

Key filing fact

Abhay U. Nayak filed Form 3 for Zoetis Inc. (ZTS) on 17 Jun 2026.

Key facts

  • This page summarizes Abhay U. Nayak's Form 3 filing for Zoetis Inc. (ZTS).
  • 0 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2026, 16:45.

Change

  • Previous filing in this sequence was filed on 11 Oct 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001797754 Primary reporting owner

Nayak Abhay U

Relationship
Executive Vice President
Address
C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Signature date
17 Jun 2026
This filing has been restated. Open the amended filing.

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZTS holding

No securities beneficially held

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
15 Jun 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,123
Exercise price
Footnotes
F2, F3, F4, F5
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,902
Exercise price
Footnotes
F2, F4, F5, F6
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
626
Exercise price
Footnotes
F2, F4, F5, F7
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
253
Exercise price
Footnotes
F2, F4, F5, F8
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,423
Exercise price
$129.13
Footnotes
F9, F10, F11
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,590
Exercise price
$156.64
Footnotes
F9, F11, F12
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,830
Exercise price
$196.14
Footnotes
F9, F11, F13
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,314
Exercise price
$162.07
Footnotes
F9, F11, F14
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,106
Exercise price
Footnotes
F11, F15, F16, F17
ZTS holding Derivative

Phantom Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,509
Exercise price
Footnotes
F18, F19
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 19 footnotes

Footnote F1

The reporting person was a Section 16 officer of Zoetis Inc., in his capacity as Executive Vice President, from January 1, 2020 to October 31, 2022, and as a result filed a Form 3 on January 8, 2020, and filed his last Form 4 on October 11, 2022. The securities reported as beneficially owned in this Form 3 reflect unreported transactions that occurred between October 11, 2022 and June 15, 2026, the date on which the reporting person again became a Section 16 officer for Zoetis Inc.

Footnote F2

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F3

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F4

Not applicable.

Footnote F5

Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F6

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, January 30, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F7

One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F8

One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F9

Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Footnote F10

One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.

Footnote F11

Each option expires on the tenth anniversary of the date of grant.

Footnote F12

One-third of each option vests on the first, second and third anniversaries of the date of grant, February 19, 2025.

Footnote F13

One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.

Footnote F14

One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.

Footnote F15

Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

Footnote F16

Each option vested on the third anniversary of the date of grant.

Footnote F17

1,147 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,658 options granted February 11, 2020 at an exercise price of $144.03 per option; 2,478 options granted February 10, 2021 at an exercise price of $160.62 per option; and 2,823 options granted February 8, 2022 at an exercise price of $201.30 per option.

Footnote F18

These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Footnote F19

Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .